Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published April 6, 2007 | Supplemental Material + Published
Journal Article Open

Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway

Abstract

Regulation of intracellular cyclic adenosine 3',5'-monophosphate (cAMP) is integral in mediating cell growth, cell differentiation, and immune responses in hematopoietic cells. To facilitate studies of cAMP regulation we developed a BRET (bioluminescence resonance energy transfer) sensor for cAMP, CAMYEL (cAMP sensor using YFP-Epac-RLuc), which can quantitatively and rapidly monitor intracellular concentrations of cAMP in vivo. This sensor was used to characterize three distinct pathways for modulation of cAMP synthesis stimulated by presumed Gs-dependent receptors for isoproterenol and prostaglandin E2. Whereas two ligands, uridine 5'-diphosphate and complement C5a, appear to use known mechanisms for augmentation of cAMP via Gq/calcium and Gi, the action of sphingosine 1-phosphate (S1P) is novel. In these cells, S1P, a biologically active lysophospholipid, greatly enhances increases in intracellular cAMP triggered by the ligands for Gs-coupled receptors while having only a minimal effect by itself. The enhancement of cAMP by S1P is resistant to pertussis toxin and independent of intracellular calcium. Studies with RNAi and chemical perturbations demonstrate that the effect of S1P is mediated by the S1P2 receptor and the heterotrimeric G13 protein. Thus in these macrophage cells, all four major classes of G proteins can regulate intracellular cAMP.

Additional Information

© 2007 the American Society for Biochemistry and Molecular Biology. Received for publication, October 16, 2006 , and in revised form, January 29, 2007. Originally published In Press as doi:10.1074/jbc.M609695200 on February 5, 2007 We thank Jana Hadas for help with protein purification and Drs. William Singer and Scott Gibson for plasmids. This work was supported by National Institutes of Health Grant GM 62114, the Robert A. Welch foundation (to P.C.S.), and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P.C.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The on-line version of this article (available at http://www.jbc.org) contains supplemental data and Figs. S1-S7.

Attached Files

Published - JIAjbc07.pdf

Supplemental Material - JIAjbc07suppdata.pdf

Files

JIAjbc07.pdf
Files (892.9 kB)
Name Size Download all
md5:1dcb4d7dba3de071a81006010e035c24
683.0 kB Preview Download
md5:a631c6bea58dd98c614b872cd69fdec4
209.9 kB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 16, 2023